Biological research can inspire technological innovation. Also, software that models computer networks can inform health care for patients with neurological disorders.
Academic rigor, journalistic flair
Articles on Alzheimer's disease
Displaying 181 - 200 of 352 articles
The Trump administration has banned NIH researchers from using fetal tissue. The tissue is an essential tool for scientists investigating diseases ranging from Alzheimer’s to Zika virus infections.
People with Down syndrome are at much higher risk of dementia than the general population. Knowing when cognitive changes start is critical for developing new drugs.
A new type of drug blocks the destruction of neurons in the eye, preventing blindness. The researchers hope that the same therapy can be applied to other common neurodegenerative diseases.
From aggressive patients with Alzheimer’s to frustrated caregivers, dementia is increasingly entwined with violence in private homes and residential facilities.
With the World Chess Championship set to begin Nov. 9 in London, Alexey Root, who teaches online courses about chess in education, tackles some myths and unknowns about the royal game.
Higher education for seniors shows promise – for combatting social isolation, increasing well-being and delaying the onset, or slowing the progression, of dementia.
New review finds that over 150 papers strongly support the view that herpes simplex plays a role in Alzheimer’s disease.
With an ageing population, dementia is becoming more and more prevalent. But what does dementia actually do to the brain to cause changes in behaviour?
Media pioneer Ted Turner’s announcement that he has Lewy body dementia brings the illness into the spotlight, which is rare. A neurologist explains why it’s hard to even get a correct diagnosis.
Trials for new Alzheimer’s drugs have been failing a lot, lately. But it may be premature to abandon these drugs altogether.
Because of their sedative effect, antipsychotic medications are often used – in fact they are over-used – to “manage” people with dementia. This is against clinical guidelines.
Alzheimer’s disease affects many people under the age of 65. The ‘young-onset’ version of the disease is often misdiagnosed as depression or dismissed as a midlife crisis.
Have you noticed your thinking ability drops during winter and spring? A new study of healthy adults and dementia patients found cognitive function declines in the colder months.
More than 16 million people in the U.S. take care of people with dementia. Could we learn something from how other cultures view dementia as more of a social disease rather than a lonely one?
For people with dementia, problems performing certain tasks can be a warning sign of difficulty managing financial tasks, according to new research.
Alzheimer’s is not only the third leading cause of death in the U.S. but also the most dreaded diagnosis. Genetic testing can help determine susceptibility, but knowing whether to test isn’t easy.
Reporting of recent studies may have caused alarm that brain injuries cause dementia. It just increases your risk.
Alzheimer’s drug development tends to focus on protein aggregates in the brain. Perhaps that’s why they’ve all failed.
While drugs have been developed to treat HIV and AIDS, the virus can still lie dormant in the brain, increasing the risk for brain disease such as Parkinson’s and Alzheimer’s diseases.
Top contributors
-
Research Fellow in Neuroimmunology, UCL
-
Associate Professor, Turner Institute for Brain and Mental Health, Monash University
-
Professor of Neurology and Neuroscience, University of Florida
-
Professor Emeritus of Molecular Neurobiology at the University of Manchester and a Visiting Professorial Fellow, University of Oxford
-
Professor of Neurology, UCL
-
Professor of Psychology in Epidemiology, UCL
-
Post grad student at University of Edinburgh, The University of Edinburgh
-
Étudiant au doctorat en psychologie, Université du Québec à Montréal (UQAM)
-
Professor of Chemistry and Senior Scientist of the Krembil Research Institute, University Health Network, University of Toronto
-
Associate Professor in Cellular Neuroscience, University of Reading
-
Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University
-
Investigations Editor, Insights, The Conversation
-
Associate Professor of Medicine and Geriatrics, University of Virginia
-
Host, The Conversation Weekly Podcast, The Conversation
-
Postdoctoral Research Fellow, Tufts University
